The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Dose reduction (DR) due to chemotherapy induced peripheral neuropathy (CIPN) in breast cancer (BC) patients (pts) in the neoadjuvant/adjuvant settings.
Bhavana Bhatnagar
No relevant relationships to disclose
Steven Gilmore
No relevant relationships to disclose
Olga G. Goloubeva
No relevant relationships to disclose
Lulu Wang
No relevant relationships to disclose
Michelle Medeiros
No relevant relationships to disclose
Saranya Chumsri
No relevant relationships to disclose
Katherine Hanna Tkaczuk
No relevant relationships to disclose
Martin J. Edelman
No relevant relationships to disclose
Ting Bao
No relevant relationships to disclose